0001683168-21-004787.txt : 20211012
0001683168-21-004787.hdr.sgml : 20211012
20211012173639
ACCESSION NUMBER: 0001683168-21-004787
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211009
FILED AS OF DATE: 20211012
DATE AS OF CHANGE: 20211012
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hart Daniel R
CENTRAL INDEX KEY: 0001346342
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32839
FILM NUMBER: 211319499
MAIL ADDRESS:
STREET 1: 2642 MICHELLE DR., SUITE 200
CITY: TUSTIN
STATE: CA
ZIP: 62780
FORMER NAME:
FORMER CONFORMED NAME: Hart Daniel Ryan
DATE OF NAME CHANGE: 20051208
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Avid Bioservices, Inc.
CENTRAL INDEX KEY: 0000704562
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 953698422
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0430
BUSINESS ADDRESS:
STREET 1: 2642 MICHELLE DRIVE, SUITE 200
CITY: TUSTIN
STATE: CA
ZIP: 92780
BUSINESS PHONE: 714.508.6100
MAIL ADDRESS:
STREET 1: 2642 MICHELLE DRIVE, SUITE 200
CITY: TUSTIN
STATE: CA
ZIP: 92780
FORMER COMPANY:
FORMER CONFORMED NAME: PEREGRINE PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20001109
FORMER COMPANY:
FORMER CONFORMED NAME: TECHNICLONE CORP/DE/
DATE OF NAME CHANGE: 19970924
FORMER COMPANY:
FORMER CONFORMED NAME: TECHNICLONE INTERNATIONAL CORP
DATE OF NAME CHANGE: 19920703
4
1
ownership.xml
X0306
4
2021-10-09
0
0000704562
Avid Bioservices, Inc.
CDMO
0001346342
Hart Daniel R
2642 MICHELLE DRIVE, SUITE 200
TUSTIN
CA
92780
0
1
0
0
Chief Financial Officer
Common Stock, $0.001 par value
2021-10-09
4
M
0
1520
A
27623
D
Common Stock, $0.001 par value
2021-10-11
4
S
0
760
22.3705
D
26863
D
Restricted Stock Units
2021-10-09
4
M
0
1520
0.0000
D
Common Stock
1520
49102
D
Each Restricted Stock Unit ("RSU") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock.
Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the RSUs listed in Table II. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the reporting person.
RSUs granted to the reporting person on July 9, 2021, vest in sixteen (16) equal quarterly installments over a four (4) year period beginning October 9, 2021 and each quarter thereafter until fully-vested, subject to the reporting person's continuous service to the Issuer on such vesting dates.
/s/ Daniel R. Hart
2021-10-12